Arthroscopic meniscus repair and augmentation with autologous fibrin clot in Indian population: A 2-year prospective study.
Sachin Kale, Sandeep Deore, Aditya Gunjotikar...
https://pubmed.ncbi.nlm.nih.gov/36035781/Actively Recruiting
Led by Ankara City Hospital Bilkent · Updated on 2025-10-02
120
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating a surgical approach for repairing longitudinal meniscal tears, which are injuries involving a displaced fragment of the meniscus that can cause knee locking, clicking, pain, and swelling. These tears mainly affect the medial meniscus and often follow traumatic knee injuries, especially in athletes. The study compares repair methods to see if adding a fibrin clot can improve healing and outcomes compared to standard meniscal repair. Participants will be randomly assigned to one of two groups one group will have routine meniscal repair surgery using arthroscopic sutures, while the other group will receive the same repair plus a fibrin clot made from bone marrow aspirate applied between the torn meniscus edges. This clot acts as a biological scaffold to promote tissue healing. Surgeries are performed under spinal anesthesia, and patients will follow the same rehabilitation plan after surgery. Participants will be followed clinically for at least one year, including MRI scans to assess healing of the meniscus. Researchers will also evaluate knee function and activity using scores like the Tegner Activity Scale, KOOS, and Tegner-Lysholm Score at one year. The main outcome is the number of patients with healed menisci on MRI after one year. The study runs from mid-2024 to mid-2029 and is led by Ankara City Hospital Bilkent.
CONDITIONS
Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears
E
Enejd Veizi, MD
Y
Yasin Erdoğan, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ankara City Hospital Bilkent
Lead Sponsor
Ankara Etlik City Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo meniscus repair surgery, either with fibrin clot augmentation or standard repair, under spinal anesthesia. Surgical wounds and portals are closed and an elastic bandage is applied.
1 surgical visit
Duration - At least 1 year
Participants follow the same postoperative rehabilitation protocol and are clinically followed for at least one year to monitor healing and recovery.
Multiple clinical follow-up visits during the year
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sachin Kale, Sandeep Deore, Aditya Gunjotikar...
https://pubmed.ncbi.nlm.nih.gov/36035781/Takuya Kinoshita, Yusuke Hashimoto, Kumi Orita...
https://pubmed.ncbi.nlm.nih.gov/36574822/Ariel N Rodriguez, Hailee Reist, Daniel J Liechti...
https://pubmed.ncbi.nlm.nih.gov/36632380/Chrysanthos Chrysanthou, Nikolaos Laliotis, George K Paraskevas...
https://pubmed.ncbi.nlm.nih.gov/38288322/Rachel E Keller, Evan A O'Donnell, Giovanna I S Medina...
https://pubmed.ncbi.nlm.nih.gov/35258647/Ankara City Hospital Bilkent
Lead Sponsor
Ankara Etlik City Hospital
Collaborating Sponsor